First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published: April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like UH researchers secure NIH grant to tackle buprenorphine’s dental side effects December 14, 2023 Anti-coagulant therapy fails to improve stroke outcomes in major study September 4, 2024 ECG-CLIP improves heart disease detection using less labeled data September 1, 2026